Cephalexin and oral cephalosporin

Cefaclor revisited.

Clinical therapeutics·2000

Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.

Transplantation·2000

Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes.

Infection control and hospital epidemiology·1998

Infectious ocular complications in orthotopic liver transplant patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1997

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1996

High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·1995

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Novel application of paeoniflorin: Stabilization of atherosclerotic plaques via the AMPK/PPARδ signaling pathway.

Vascular pharmacology·2026

cAmbly, a peptide derived from the star tick Amblyomma sculptum salivary gland transcriptome, attenuates inflammatory pain by activating endogenous opioid pathways.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Computationally Assisted Peptide Screening to Identify Sequences from Reported Peptides to Achieve Enhance Abilities in Supporting Adhesion and Self-Renewal of Human Pluripotent Stem Cell Cultures.

ACS applied bio materials·2026

Protein-protein interaction inhibitors in the human proteome: lessons from 117 targeted interactions.

RSC medicinal chemistry·2026

Correlative study of Parnassia palustris extract on orthotopic glioma suppression and gut microbiota modulation in mice.

Frontiers in microbiology·2026

Structural basis of HSL3/NUT receptor kinase-mediated recognition of a disulfide-constrained phytocytokine.

Plant communications·2026

Related Experiment Videos

Cephalexin and oral cephalosporin

Related Concept Videos

Cefaclor revisited.

Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.

Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes.

Infectious ocular complications in orthotopic liver transplant patients.

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.

High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Novel application of paeoniflorin: Stabilization of atherosclerotic plaques via the AMPK/PPARδ signaling pathway.

cAmbly, a peptide derived from the star tick Amblyomma sculptum salivary gland transcriptome, attenuates inflammatory pain by activating endogenous opioid pathways.

Computationally Assisted Peptide Screening to Identify Sequences from Reported Peptides to Achieve Enhance Abilities in Supporting Adhesion and Self-Renewal of Human Pluripotent Stem Cell Cultures.

Protein-protein interaction inhibitors in the human proteome: lessons from 117 targeted interactions.

Correlative study of Parnassia palustris extract on orthotopic glioma suppression and gut microbiota modulation in mice.

Structural basis of HSL3/NUT receptor kinase-mediated recognition of a disulfide-constrained phytocytokine.

Related Experiment Videos

Cephalexin and oral cephalosporin

Related Concept Videos

Related Articles